ImmuneOnco Biopharmaceuticals (Shanghai) Inc. (1541.HK)
HKD 5.05
(0.0%)
HKD 5.05
(0.0%)
| Year | Eps | Eps Growth |
|---|---|---|
| 2023 | -1.05 CNY | 2.78% |
| 2022 | -1.08 CNY | 44.9% |
| 2021 | -1.96 CNY | 0.0% |
| Year | Eps | Eps Growth |
|---|---|---|
| 2024 Q1 | -0.24 HKD | 59.2% |
| 2024 Q2 | -0.24 HKD | -8.27% |
| 2023 Q4 | -0.60 HKD | -100.0% |
| 2023 FY | - CNY | 2.78% |
| 2023 Q3 | -0.30 HKD | 42.31% |
| 2023 Q2 | -0.52 HKD | -92.59% |
| 2023 Q1 | -0.27 HKD | 52.63% |
| 2022 FY | - CNY | 44.9% |
| 2022 Q4 | -0.57 HKD | -90.0% |
| 2022 Q3 | -0.30 HKD | 55.88% |
| 2022 Q2 | -0.68 HKD | 0.0% |
| 2021 FY | - CNY | 0.0% |
| Name | Eps | Eps Difference |
|---|---|---|
| Uni-Bio Science Group Limited | 0.01 HKD | 9559.459% |
| CK Life Sciences Int'l., (Holdings) Inc. | 0.00 HKD | 58433.333% |